Results 181 to 190 of about 6,631 (231)

Genetic and Clinical Characterization of a Large Cohort with Suspected Monogenic Stone Disease. [PDF]

Clin J Am Soc Nephrol
Cogal AG, Ali AE, Arnous MG, Alhadi A, Zhou LT, Arroyo J, Seide BM, Rossler KJ, Reynolds LM, Kennedy GN, Elbarougy DE, Goldfarb DS, Milliner DS, Sas DJ, Lieske JC, Harris PC, Investigators of the Rare Kidney Stone Consortium.   +16 more
europepmc   +1 more source

Genetics of kidney stones and the role of genetic testing in prevention: a guide for urologists. [PDF]

Front Med (Lausanne)
Pintus F, Giordano N, Giordano N, Giachino DF, Mandrile G.   +4 more
europepmc   +1 more source

[Cystinuria].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2003
F, Rousaud, M, Palacín, V, Nunes
openaire   +1 more source

Cystinuria

, 2017
Matt Morgan, Daniel Bell, Matt Adams
openaire   +1 more source

The effect of selenium supplementation on cystine crystal volume in patients with cystinuria

Mehrdad Mohammadi Sichani, Amin Shohani, Hatef Khorami, Kia Nouri Mahdavi, Mohammad Hossein Izadpanahi, Farshid Alizadeh, Mohammad Azizi   +6 more
openalex   +2 more sources

Whole-exome sequencing of kidney transplant recipients and donors: insights into end-stage renal disease and post-transplant genetic risk. [PDF]

BMC Nephrol
Bayanova M, Bolatov A, Malik D, Sapargaliyeva M, Abdikadirova A, Zhenissova A, Nazarova L, Assykbayev M, Abdugafarov S, Rakhimzhanova S, Suleimenova D, Kuttymuratov G, Ainakulov A, Sailybayeva A, Altynova S, Pya Y.   +15 more
europepmc   +1 more source

Cystine crystal nucleation and decay in the context of cystinuria pathogenesis and treatment. [PDF]

RSC Adv
Noble K, Kavanagh ON.
europepmc   +1 more source

8-l-Cystinyl Bis(1,8-diazaspiro[4.5]decane) as an Orally Bioavailable l-Cystine Crystallization Inhibitor for Cystinuria. [PDF]

ACS Med Chem Lett
Hu L, Albanyan H, Yang J, Wang Y, Yang M, Tan X, Zhong X, Ward MD, Sahota A.   +8 more
europepmc   +1 more source